Novavax says its COVID-19 vaccine is more than 90 per cent effective

Novavax says its COVID-19 vaccine is more than 90 per cent effective

SBS

Published

Novavax says late-stage data from its US-based clinical trial shows its vaccine is more than 90 per cent effective against COVID-19.

Full Article